经同一微导管序贯递送二甲基亚砜基非黏附性液体栓塞剂治疗脑动静脉畸形
2018年3月至2019年3月,16例脑动静脉畸形患者经同一微导管序贯使用PHIL 30%与Menox 18栓塞,回流达约2 cm时切换,平均体积缩小85%,完全栓塞10/16(62.5%),无手术相关并发症及临床恶化,作者认为该技术安全有效但需进一步研究验证。
要点
- 回流长度约2 cm时由PHIL 30%切换为Menox 18,全部16例均见顺行血流与远端渗透。
- 平均体积缩小85%(范围50%–100%),完全栓塞10/16(62.5%)。
- 无手术相关并发症、无死亡及术后临床恶化。
关键影像表现/征象
- 经21条供血动脉支完成经同一微导管的PHIL与Menox联合栓塞。
- 回流长度达约2 cm时由PHIL 30%切换为Menox 18。
- 全部16例均见序贯所用液体栓塞剂的顺行血流和远端渗透。
- 所有栓塞操作均能完全控制材料流动并避免危险的近端回流。
诊断标准与关键数值
- 按Spetzler-Martin分级:I–II级11例(68.75%),III级4例(25%),IV级1例(6.25%)。
- 估计平均体积缩小85%,范围50%–100%。
- 完全栓塞10/16例(62.5%)。
- 10/16例患者经至少1次随访血管造影确认临床成功和完全闭塞。
临床应用与阅片要点
- 回流长度达约2 cm时由PHIL 30%切换为Menox 18,以实现远端渗透并避免近端回流。
- 作者认为该技术可能成为脑动静脉畸形常规治疗的潜在技术。
- 作者指出需进一步研究验证该方法的安全性和有效性。
局限性
- 原文作者指出需进一步研究验证该方法的安全性和有效性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: Conventional nonadhesive liquid embolic agents currently are the criterion standard for endovascular embolization of cerebral AVMs. However, inadequate distal penetration into the nidus and unstable proximal plug formation are the major limitations of this approach and of the currently available embolic materials. The aim of this study was to evaluate the hypothetic efficacy of combining liquid embolic agents with different properties and viscosities for use in endovascular embolization of cerebral AVMs.
MATERIALS AND METHODS: From March 2018 to March 2019, sixteen patients with cerebral AVMs (12 women, 4 men; age range, 33-61 years) underwent endovascular embolization with combined liquid embolic agents delivered serially via a single microcatheter. The procedure consists of initial embolization with PHIL 30%, followed by Menox 18 through the same microcatheter. According to the Spetzler-Martin scale, 11 (68.75%) AVMs were grades I-II, 4 (25%) were grade III, and 1 (6.25%) was grade IV. Angiographic, technical, and clinical outcomes were analyzed independently.
RESULTS: Combined PHIL and Menox embolization through the same microcatheter via 21 pedicles was performed in these 16 patients. Once the length of the reflux reached approximately 2 cm, PHIL 30% was switched to Menox 18. Antegrade flow and distal penetration of the serially applied liquid embolic agents were observed in all 16 cases. The ability to completely control the flow of the materials and avoid any dangerous proximal reflux was noted in all performed embolizations. The estimated average size reduction of the treated AVMs was 85%, ranging from 50% to 100%. Complete embolization was achieved in 10/16 or 62.5% of the cases. There was no procedure-related complication during or after the embolization. No mortality or postprocedural clinical worsening was seen. Clinical success and complete obliteration were confirmed with at least 1 follow-up angiography in 10/16 patients.
CONCLUSIONS: Serial delivery of nonadhesive liquid embolic agents via the same microcatheter was safe and effective in our study and may be a potential technique for routine AVM treatment. However, further investigations are required to validate the safety and the efficacy of the method.
引用
- Sirakov A, Minkin K, Sirakov S, et al. Intermixed Dimethyl-Sulfoxide-Based Nonadhesive Liquid Embolic Agents Delivered Serially via the Same Microcatheter for Cerebral AVM Treatment. AJNR Am J Neuroradiol. 2020. PMID: 32165357. doi:10.3174/ajnr.A6453
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。